BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6505446)

  • 1. The surgical management of advanced abdominal disease.
    Richie JP
    Semin Urol; 1984 Nov; 2(4):238-43. PubMed ID: 6505446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modified lymphadenectomy in testicular tumor].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):208. PubMed ID: 1514201
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance pf retroperitoneal lymphadenectomy in the treatment of disseminated germinogenic testicular tumors after induction chemotherapy].
    Mitin AV; Figurin KM; Matveev BP; Tiuliandin SA; Bukharin BV; Volkova MI; Matveev VB
    Urologiia; 2000; (6):12-6. PubMed ID: 11186312
    [No Abstract]   [Full Text] [Related]  

  • 7. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of testicular cancer: a surgeon's view.
    Dindyal S; Bhuva N; Sooriakumaran P
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):109-12. PubMed ID: 15757443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview: treatment of local regional disease.
    Donohue JP
    Prog Clin Biol Res; 1990; 350():283-93. PubMed ID: 2166958
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of nonseminomatous testicular tumor with minimal retroperitoneal lymph node involvement.
    Pontes JE
    Prog Clin Biol Res; 1985; 203():579-83. PubMed ID: 2421343
    [No Abstract]   [Full Text] [Related]  

  • 11. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
    Heidenreich A; Thüer D; Polyakov S
    Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed?
    Solé-Balcells F; Villavicencio H; Germá R
    Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the treatment of testicular tumors].
    Perry H; Luria H; Servadio C
    Harefuah; 1985 Feb; 108(3):124-6. PubMed ID: 4007647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
    Brudermanns B
    Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of advanced testicular cancer.
    Williams SD; Loehrer PJ; Einhorn LH
    Semin Urol; 1984 Nov; 2(4):230-7. PubMed ID: 6209762
    [No Abstract]   [Full Text] [Related]  

  • 16. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
    Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of germ cell tumors of the testis: an overview.
    Skinner DG
    Semin Urol; 1984 Nov; 2(4):189-93. PubMed ID: 6095393
    [No Abstract]   [Full Text] [Related]  

  • 18. High versus low-dose cisplatin combined with vinblastine and bleomycin and selective surgical resection of residual disease in patients with disseminated testicular cancer: a Southwest Oncology Group Study.
    Crawford ED; Samson M; Klugo RC; Dawkins CA; Davis M
    Prog Clin Biol Res; 1985; 203():363-80. PubMed ID: 2421331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
    Matsuzaki M; Nakano M; Komatsu H; Ohashi K
    Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
    Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.